Skip to main content

Gilead Sciences battles U.S. government in court over HIV prevention patent

The U.S. claims Gilead's drugs Truvada and Descovy infringe on CDC patents.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.